MLEC Stock Overview
Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
Moolec Science SA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$1.45 |
52 Week High | US$4.40 |
52 Week Low | US$1.15 |
Beta | -0.47 |
1 Month Change | 5.07% |
3 Month Change | -20.77% |
1 Year Change | -47.65% |
3 Year Change | -85.22% |
5 Year Change | n/a |
Change since IPO | -85.22% |
Recent News & Updates
Shareholder Returns
MLEC | US Food | US Market | |
---|---|---|---|
7D | 3.6% | 1.0% | 2.9% |
1Y | -47.7% | -13.1% | 22.2% |
Return vs Industry: MLEC underperformed the US Food industry which returned -11.9% over the past year.
Return vs Market: MLEC underperformed the US Market which returned 21.9% over the past year.
Price Volatility
MLEC volatility | |
---|---|
MLEC Average Weekly Movement | 25.7% |
Food Industry Average Movement | 4.7% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: MLEC's share price has been volatile over the past 3 months.
Volatility Over Time: MLEC's weekly volatility has increased from 16% to 26% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2020 | 45 | Gaston Paladini | moolecscience.com |
Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America.
Moolec Science SA Fundamentals Summary
MLEC fundamental statistics | |
---|---|
Market cap | US$54.47m |
Earnings (TTM) | -US$6.48m |
Revenue (TTM) | US$2.90m |
18.8x
P/S Ratio-8.4x
P/E RatioIs MLEC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MLEC income statement (TTM) | |
---|---|
Revenue | US$2.90m |
Cost of Revenue | US$2.59m |
Gross Profit | US$309.18k |
Other Expenses | US$6.79m |
Earnings | -US$6.48m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.17 |
Gross Margin | 10.67% |
Net Profit Margin | -223.70% |
Debt/Equity Ratio | 117.4% |
How did MLEC perform over the long term?
See historical performance and comparison